Sofinnova Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sofinnova Investments's BMY Position: Q2 2026 in Review
Sofinnova Investments reduced its Bristol-Myers Squibb (BMY) stake by 56% in Q2 2026, selling an estimated $63.8M and leaving 876,970 shares worth $50.5M. The position accounts for 2.61% of the portfolio, ranked #10.
Sofinnova Investments first reported a position in BMY in Q1 2018 and has held it in 7 quarters since. The position peaked at $121M in Q1 2026. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Sofinnova Investments held 876,970 shares of Bristol-Myers Squibb worth $50.5M as of Q2 2026.
- Sofinnova Investments sold 1,111,751 Bristol-Myers Squibb shares in Q2 2026, an estimated $63.8M.
- Bristol-Myers Squibb made up 2.61% of Sofinnova Investments's portfolio in Q2 2026, its #10 holding.
- Sofinnova Investments first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 7 quarters since.
- Sofinnova Investments's Bristol-Myers Squibb position peaked at $121M in Q1 2026.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.